Naringenin inhibits the upregulation of CYP 3A4 and attenuates the cellular toxicity induced by rifampicin and isoniazid in hepatocytes
- VernacularTitle:柑桔素抑制CYP450 3A4活性并减轻异烟肼和利福平合用的肝细胞毒性
- Author:
Zhihua ZHANG
;
Honghai WU
;
Gai XUE
;
Dingni GUO
;
Yanning HOU
- Publication Type:Journal Article
- Keywords:
isoniazid;
rifampicin;
naringenin;
QSG-7701 cell;
hepatotoxicity;
lactate dehydrogenase;
cytochrome enzyme
- From:
Chinese Pharmacological Bulletin
2009;25(12):1619-1622
- CountryChina
- Language:Chinese
-
Abstract:
Aim To investigate the protective effect of naringenin on isoniazid and rifampicin induced hepatotoxicity and the role of CYP 3A4.Methods Isoniazid and rifampicin were added to culture media for QSG-7701 cells and cultured for 48 hours. Narringenin, 1,5 and 25 mg·L~(-1) in final concentration,was added concomitant with isoniazid and rifampicin. The culture media and cells were collected and the activities of lactate dehydrogenase were detected with chromatometry. The ratio of extra/intracellular lactate dehydrogenase was calculated as the release rate of lactate dehydrogenase. Cells were incubated with midazolam for 2 hours after treatment with durgs and the concentration of midazolam in the incubation media was determined with HPLC-MS.Results Compared with control group, isoniazid and rifampicin treatment increased lactate dehydrogenase release and CYP 3A4 activity significantly. Naringenin attenuated the effect of isoniazid and rifampicin on lactate dehydrogenase and CYP 3A4 activity.Conclusion Naringenin can attenuate the hepatotoxicity of isoniazid and rifampicin through inhibiting the activity of CYP 3A4 in cultured hepatocytes.
